Literature DB >> 33786471

Vaso-Occlusive Pain and Menstruation in Sickle Cell Disease: A Focus Group Analysis.

Melissa Day1, Kemberlee Bonnet2, David G Schlundt2, Michael DeBaun1, Deva Sharma1.   

Abstract

Background: Acute vaso-occlusive pain, herein referred to as acute sickle cell disease (SCD) pain, associated with menstruation has received little attention. Key unanswered questions include how women differentiate acute SCD pain and menstrual cramps, and how both types of pain impact quality of life.
Methods: Using inductive/deductive qualitative research methods, three focus groups were conducted to understand the patient experience of acute SCD pain associated with menstruation.
Results: Fourteen women with SCD participated in our focus groups. Major themes were identified: (1) clinical sequelae of SCD surrounding menstruation, (2) coping with psychosocial challenges, (3) interpersonal difficulties and support systems, (4) impacts on quality of life, (5) impacts on emotional well-being, and (6) proposed solutions for health care systems. Conclusions: Women with SCD can distinguish acute SCD pain from menstrual cramps. Health care providers should become more familiar with acute SCD pain associated with menstruation and encourage a patient-centered dialogue to determine appropriate courses of action. © Melissa Day et al. 2020; Published by Mary Ann Liebert, Inc.

Entities:  

Keywords:  menstruation; sickle cell disease; vaso-occlusive pain

Year:  2020        PMID: 33786471      PMCID: PMC7784793          DOI: 10.1089/whr.2019.0008

Source DB:  PubMed          Journal:  Womens Health Rep (New Rochelle)        ISSN: 2688-4844


  16 in total

1.  Menstrual pattern in women with sickle cell anaemia and its association with sickling crises.

Authors:  W C Yoong; S M Tuck
Journal:  J Obstet Gynaecol       Date:  2002-07       Impact factor: 1.246

2.  Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.

Authors:  Allison Tong; Peter Sainsbury; Jonathan Craig
Journal:  Int J Qual Health Care       Date:  2007-09-14       Impact factor: 2.038

3.  The cost of health care for patients with sickle cell disease.

Authors:  Samir K Ballas
Journal:  Am J Hematol       Date:  2009-06       Impact factor: 10.047

4.  Human agency in social cognitive theory.

Authors:  A Bandura
Journal:  Am Psychol       Date:  1989-09

5.  Steroid treatment in the prevention of painful episodes in sickle-cell disease.

Authors:  W A Isaacs; C E Effiong; O Ayeni
Journal:  Lancet       Date:  1972-03-11       Impact factor: 79.321

Review 6.  A cognitive-affective system theory of personality: reconceptualizing situations, dispositions, dynamics, and invariance in personality structure.

Authors:  W Mischel; Y Shoda
Journal:  Psychol Rev       Date:  1995-04       Impact factor: 8.934

7.  Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients.

Authors:  M de Abood; Z de Castillo; F Guerrero; M Espino; K L Austin
Journal:  Contraception       Date:  1997-11       Impact factor: 3.375

8.  The cost of health care for children and adults with sickle cell disease.

Authors:  Teresa L Kauf; Thomas D Coates; Liu Huazhi; Nikita Mody-Patel; Abraham G Hartzema
Journal:  Am J Hematol       Date:  2009-06       Impact factor: 10.047

9.  The painful crisis of homozygous sickle cell disease: clinical features.

Authors:  G R Serjeant; C D Ceulaer; R Lethbridge; J Morris; A Singhal; P W Thomas
Journal:  Br J Haematol       Date:  1994-07       Impact factor: 6.998

10.  Painful crises and menstruation in sickle cell disease.

Authors:  J Samuels-Reid; R B Scott
Journal:  South Med J       Date:  1985-04       Impact factor: 0.954

View more
  1 in total

Review 1.  Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease.

Authors:  Lydia H Pecker; Deva Sharma; Alecia Nero; Michael J Paidas; Russell E Ware; Andra H James; Kim Smith-Whitley
Journal:  Br J Haematol       Date:  2021-07-07       Impact factor: 8.615

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.